Using a CRISPR/Cas9 mediated TMEM165 knockout in the human breast cancer cell line MDAMB231 we find that TMEM165 deletion impaired invasive and migratory properties in vitro and tumor growth in vivo. Here, TMEM165 is linked to breast carcinoma.